Alistair Wilson

Statistics

Publications

Citations

548

H-Index

Active since

1998

Affiliations

Rush University Medical Center(Current)

Washington University in St. Louis

Cereneo

Alistair Wilson is an author at Rush University Medical Center specializing in neuroscience, neurodegenerative diseases, and neurodegenerative disorders.

Publications per year

1998–2013

Publications

Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains

Raymond T. Bartus, Christopher D. Herzog, Yaping Chu et al. · Movement Disorders · 2010 · 169 citations

Life Sciences, Neurology, Neuroscience +17

AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson’s disease

Mehdi Gasmi, Eugene P. Brandon, Christopher D. Herzog et al. · Neurobiology of Disease · 2007 · 141 citations · Full text

Medicine, Neurology, Neuroscience +17

EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE

Christopher D. Herzog, Lamar Brown, Dawn Gammon et al. · Neurosurgery · 2009 · 75 citations

Life Sciences, Neurobiology, Neuroscience +17

Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease

Raymond T. Bartus, Lamar Brown, Alistair Wilson et al. · Neurobiology of Disease · 2011 · 62 citations · Full text

Medicine, Neurology, Neuroscience +16

Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120)

Christopher D. Herzog, Lamar Brown, Brian Kruegel et al. · Neurobiology of Disease · 2013 · 44 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

1–5 of 7